Drug Eluting Balloons-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data


Report ID : RNR-247957 Category : Medical Devices Published Date : 4-Mar-19
Publisher : MIReports Pages : 145 Format : PDF
Report Summary

Drug Eluting Balloons-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Drug Eluting Balloons industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Worldwide and Top 20 Countries Market Size of Drug Eluting Balloons 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Drug Eluting Balloons worldwide and market share by regions, with company and product introduction, position in the Drug Eluting Balloons market
Market status and development trend of Drug Eluting Balloons by types and applications
Cost and profit status of Drug Eluting Balloons, and marketing status
Market growth drivers and challenges

The report segments the global Drug Eluting Balloons market as:

Global Drug Eluting Balloons Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa

Global Drug Eluting Balloons Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Peripheral DEBs 
Coronary DEBs

Global Drug Eluting Balloons Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Cath labs 
Hospitals 
Ambulatory surgical centers (ASCs)

Global Drug Eluting Balloons Market: Manufacturers Segment Analysis (Company and Product introduction, Drug Eluting Balloons Sales Volume, Revenue, Price and Gross Margin):
B. Braun Melsungen 
Cook Medical 
C.R. Bard 
Eurocor 
Medtronic 
Aachen Resonance 
Acrostak 
Cardionovum 
Spectranetics
NEUROPACE 
NDI MEDICAL 
NEVRO

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Contents
Chapter 1 Overview of Drug Eluting Balloons
    1.1 Definition of Drug Eluting Balloons in This Report
    1.2 Commercial Types of Drug Eluting Balloons
        1.2.1 Peripheral DEBs 
        1.2.2 Coronary DEBs
    1.3 Downstream Application of Drug Eluting Balloons
        1.3.1 Cath labs 
        1.3.2 Hospitals 
        1.3.3 Ambulatory surgical centers (ASCs)
    1.4 Development History of Drug Eluting Balloons
    1.5 Market Status and Trend of Drug Eluting Balloons 2013-2023
        1.5.1 Global Drug Eluting Balloons Market Status and Trend 2013-2023
        1.5.2 Regional Drug Eluting Balloons Market Status and Trend 2013-2023
Chapter 2 Global Market Status and Forecast by Regions
    2.1 Market Development of Drug Eluting Balloons 2013-2017
    2.2 Sales Market of Drug Eluting Balloons by Regions
        2.2.1 Sales Volume of Drug Eluting Balloons by Regions
        2.2.2 Sales Value of Drug Eluting Balloons by Regions
    2.3 Production Market of Drug Eluting Balloons by Regions
    2.4 Global Market Forecast of Drug Eluting Balloons 2018-2023
        2.4.1 Global Market Forecast of Drug Eluting Balloons 2018-2023
        2.4.2 Market Forecast of Drug Eluting Balloons by Regions 2018-2023
Chapter 3 Global Market Status and Forecast by Types
    3.1 Sales Volume of Drug Eluting Balloons by Types
    3.2 Sales Value of Drug Eluting Balloons by Types
    3.3 Market Forecast of Drug Eluting Balloons by Types
Chapter 4 Global Market Status and Forecast by Downstream Industry
    4.1 Global Sales Volume of Drug Eluting Balloons by Downstream Industry
    4.2 Global Market Forecast of Drug Eluting Balloons by Downstream Industry
Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry
    5.1 North America Drug Eluting Balloons Market Status by Countries
        5.1.1 North America Drug Eluting Balloons Sales by Countries (2013-2017)
        5.1.2 North America Drug Eluting Balloons Revenue by Countries (2013-2017)
        5.1.3 United States Drug Eluting Balloons Market Status (2013-2017)
        5.1.4 Canada Drug Eluting Balloons Market Status (2013-2017)
        5.1.5 Mexico Drug Eluting Balloons Market Status (2013-2017)
    5.2 North America Drug Eluting Balloons Market Status by Manufacturers
    5.3 North America Drug Eluting Balloons Market Status by Type (2013-2017)
        5.3.1 North America Drug Eluting Balloons Sales by Type (2013-2017)
        5.3.2 North America Drug Eluting Balloons Revenue by Type (2013-2017)
    5.4 North America Drug Eluting Balloons Market Status by Downstream Industry (2013-2017)
Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry
    6.1 Europe Drug Eluting Balloons Market Status by Countries
        6.1.1 Europe Drug Eluting Balloons Sales by Countries (2013-2017)
        6.1.2 Europe Drug Eluting Balloons Revenue by Countries (2013-2017)
        6.1.3 Germany Drug Eluting Balloons Market Status (2013-2017)
        6.1.4 UK Drug Eluting Balloons Market Status (2013-2017)
        6.1.5 France Drug Eluting Balloons Market Status (2013-2017)
        6.1.6 Italy Drug Eluting Balloons Market Status (2013-2017)
        6.1.7 Russia Drug Eluting Balloons Market Status (2013-2017)
        6.1.8 Spain Drug Eluting Balloons Market Status (2013-2017)
        6.1.9 Benelux Drug Eluting Balloons Market Status (2013-2017)
    6.2 Europe Drug Eluting Balloons Market Status by Manufacturers
    6.3 Europe Drug Eluting Balloons Market Status by Type (2013-2017)
        6.3.1 Europe Drug Eluting Balloons Sales by Type (2013-2017)
        6.3.2 Europe Drug Eluting Balloons Revenue by Type (2013-2017)
    6.4 Europe Drug Eluting Balloons Market Status by Downstream Industry (2013-2017)
Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry
    7.1 Asia Pacific Drug Eluting Balloons Market Status by Countries
        7.1.1 Asia Pacific Drug Eluting Balloons Sales by Countries (2013-2017)
        7.1.2 Asia Pacific Drug Eluting Balloons Revenue by Countries (2013-2017)
        7.1.3 China Drug Eluting Balloons Market Status (2013-2017)
        7.1.4 Japan Drug Eluting Balloons Market Status (2013-2017)
        7.1.5 India Drug Eluting Balloons Market Status (2013-2017)
        7.1.6 Southeast Asia Drug Eluting Balloons Market Status (2013-2017)
        7.1.7 Australia Drug Eluting Balloons Market Status (2013-2017)
    7.2 Asia Pacific Drug Eluting Balloons Market Status by Manufacturers
    7.3 Asia Pacific Drug Eluting Balloons Market Status by Type (2013-2017)
        7.3.1 Asia Pacific Drug Eluting Balloons Sales by Type (2013-2017)
        7.3.2 Asia Pacific Drug Eluting Balloons Revenue by Type (2013-2017)
    7.4 Asia Pacific Drug Eluting Balloons Market Status by Downstream Industry (2013-2017)
Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry
    8.1 Latin America Drug Eluting Balloons Market Status by Countries
        8.1.1 Latin America Drug Eluting Balloons Sales by Countries (2013-2017)
        8.1.2 Latin America Drug Eluting Balloons Revenue by Countries (2013-2017)
        8.1.3 Brazil Drug Eluting Balloons Market Status (2013-2017)
        8.1.4 Argentina Drug Eluting Balloons Market Status (2013-2017)
        8.1.5 Colombia Drug Eluting Balloons Market Status (2013-2017)
    8.2 Latin America Drug Eluting Balloons Market Status by Manufacturers
    8.3 Latin America Drug Eluting Balloons Market Status by Type (2013-2017)
        8.3.1 Latin America Drug Eluting Balloons Sales by Type (2013-2017)
        8.3.2 Latin America Drug Eluting Balloons Revenue by Type (2013-2017)
    8.4 Latin America Drug Eluting Balloons Market Status by Downstream Industry (2013-2017)
Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry
    9.1 Middle East and Africa Drug Eluting Balloons Market Status by Countries
        9.1.1 Middle East and Africa Drug Eluting Balloons Sales by Countries (2013-2017)
        9.1.2 Middle East and Africa Drug Eluting Balloons Revenue by Countries (2013-2017)
        9.1.3 Middle East Drug Eluting Balloons Market Status (2013-2017)
        9.1.4 Africa Drug Eluting Balloons Market Status (2013-2017)
    9.2 Middle East and Africa Drug Eluting Balloons Market Status by Manufacturers
    9.3 Middle East and Africa Drug Eluting Balloons Market Status by Type (2013-2017)
        9.3.1 Middle East and Africa Drug Eluting Balloons Sales by Type (2013-2017)
        9.3.2 Middle East and Africa Drug Eluting Balloons Revenue by Type (2013-2017)
    9.4 Middle East and Africa Drug Eluting Balloons Market Status by Downstream Industry (2013-2017)
Chapter 10 Market Driving Factor Analysis of Drug Eluting Balloons
    10.1 Global Economy Situation and Trend Overview
    10.2 Drug Eluting Balloons Downstream Industry Situation and Trend Overview
Chapter 11 Drug Eluting Balloons Market Competition Status by Major Manufacturers
    11.1 Production Volume of Drug Eluting Balloons by Major Manufacturers
    11.2 Production Value of Drug Eluting Balloons by Major Manufacturers
    11.3 Basic Information of Drug Eluting Balloons by Major Manufacturers
        11.3.1 Headquarters Location and Established Time of Drug Eluting Balloons Major Manufacturer
        11.3.2 Employees and Revenue Level of Drug Eluting Balloons Major Manufacturer
    11.4 Market Competition News and Trend
        11.4.1 Merger, Consolidation or Acquisition News
        11.4.2 Investment or Disinvestment News
        11.4.3 New Product Development and Launch
Chapter 12 Drug Eluting Balloons Major Manufacturers Introduction and Market Data
    12.1 B. Braun Melsungen 
        12.1.1 Company profile
        12.1.2 Representative Drug Eluting Balloons Product
        12.1.3 Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of B. Braun Melsungen 
    12.2 Cook Medical 
        12.2.1 Company profile
        12.2.2 Representative Drug Eluting Balloons Product
        12.2.3 Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of Cook Medical 
    12.3 C.R. Bard 
        12.3.1 Company profile
        12.3.2 Representative Drug Eluting Balloons Product
        12.3.3 Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of C.R. Bard 
    12.4 Eurocor 
        12.4.1 Company profile
        12.4.2 Representative Drug Eluting Balloons Product
        12.4.3 Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of Eurocor 
    12.5 Medtronic 
        12.5.1 Company profile
        12.5.2 Representative Drug Eluting Balloons Product
        12.5.3 Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of Medtronic 
    12.6 Aachen Resonance 
        12.6.1 Company profile
        12.6.2 Representative Drug Eluting Balloons Product
        12.6.3 Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of Aachen Resonance 
    12.7 Acrostak 
        12.7.1 Company profile
        12.7.2 Representative Drug Eluting Balloons Product
        12.7.3 Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of Acrostak 
    12.8 Cardionovum 
        12.8.1 Company profile
        12.8.2 Representative Drug Eluting Balloons Product
        12.8.3 Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of Cardionovum 
    12.9 Spectranetics
        12.9.1 Company profile
        12.9.2 Representative Drug Eluting Balloons Product
        12.9.3 Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of Spectranetics
    12.10 NEUROPACE 
        12.10.1 Company profile
        12.10.2 Representative Drug Eluting Balloons Product
        12.10.3 Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of NEUROPACE 
    12.11 NDI MEDICAL 
        12.11.1 Company profile
        12.11.2 Representative Drug Eluting Balloons Product
        12.11.3 Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of NDI MEDICAL 
    12.12 NEVRO
        12.12.1 Company profile
        12.12.2 Representative Drug Eluting Balloons Product
        12.12.3 Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of NEVRO
Chapter 13 Upstream and Downstream Market Analysis of Drug Eluting Balloons
    13.1 Industry Chain of Drug Eluting Balloons
    13.2 Upstream Market and Representative Companies Analysis
    13.3 Downstream Market and Representative Companies Analysis
Chapter 14 Cost and Gross Margin Analysis of Drug Eluting Balloons
    14.1 Cost Structure Analysis of Drug Eluting Balloons
    14.2 Raw Materials Cost Analysis of Drug Eluting Balloons
    14.3 Labor Cost Analysis of Drug Eluting Balloons
    14.4 Manufacturing Expenses Analysis of Drug Eluting Balloons
Chapter 15 Report Conclusion
Chapter 16 Research Methodology and Reference
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Reference